Transcat, Inc. (NASDAQ:TRNS) Stock Position Lifted by T. Rowe Price Investment Management Inc.

T. Rowe Price Investment Management Inc. boosted its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 178.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 518,597 shares of the scientific and technical instruments company's stock after buying an additional 332,064 shares during the quarter. T. Rowe Price Investment Management Inc. owned approximately 5.57% of Transcat worth $54,837,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of TRNS. Geode Capital Management LLC increased its holdings in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock valued at $26,269,000 after acquiring an additional 11,106 shares during the last quarter. Neuberger Berman Group LLC increased its stake in Transcat by 1.8% during the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company's stock valued at $92,415,000 after purchasing an additional 15,723 shares during the last quarter. Annex Advisory Services LLC lifted its position in shares of Transcat by 47.6% in the 4th quarter. Annex Advisory Services LLC now owns 24,461 shares of the scientific and technical instruments company's stock worth $2,587,000 after buying an additional 7,893 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Transcat by 4.1% in the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company's stock valued at $1,306,000 after buying an additional 486 shares during the period. Finally, Barclays PLC grew its position in shares of Transcat by 393.0% during the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock valued at $1,826,000 after buying an additional 12,061 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

Insider Buying and Selling

In related news, Director Craig D. Cairns purchased 1,200 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The stock was acquired at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the transaction, the director now directly owns 1,910 shares of the company's stock, valued at $147,108.20. This trade represents a 169.01 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on TRNS. HC Wainwright decreased their target price on Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. Northland Securities reissued a "market perform" rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Oppenheimer lowered shares of Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Finally, StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a research note on Wednesday, February 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $111.50.

Transcat Price Performance

Shares of NASDAQ:TRNS traded down $0.52 during trading hours on Thursday, hitting $78.82. 16,997 shares of the company's stock traded hands, compared to its average volume of 74,772. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The company's fifty day simple moving average is $77.01 and its two-hundred day simple moving average is $93.69. Transcat, Inc. has a 52 week low of $67.56 and a 52 week high of $147.12. The company has a market cap of $733.69 million, a price-to-earnings ratio of 42.69 and a beta of 0.67.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period last year, the business earned $0.56 EPS. As a group, equities analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.